Jean-Philippe Guégan

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Advanced Non Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science signaling

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Alban Bessede, Florent Peyraud, Sylvestre Le Moulec, Sophie Cousin, Mathilde Cabart, François Chomy, Christophe Rey, Oren Lara, Ophélie Odin, Imane Nafia, Jean-Philippe Guégan, Antoine Italiano
Upregulation of Indoleamine 2,3-dioxygenase 1 in tumor cells and tertiary lymphoid structures is a hallmark of inflamed non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alban Bessede, Florent Peyraud, Benjamin Besse, Sophie Cousin, Mathilde Cabart, François Chomy, Christophe Rey, Oren Lara, Ophélie Odin, Imane Nafia, Lucile Vanhersecke, Fabrice Barlesi, Jean-Philippe Guégan, Antoine Italiano
TROP2 is associated with primary resistance to immune checkpoint inhibition in patients with advanced non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Stephanie Verbeke, Aurelien Bourdon, Jean-Philippe Guégan, Laura Leroy, Vanessa Chaire, Elodie Richard, Alban Bessede, Antoine Italiano
Antitumor effects of PRMT5 inhibition in sarcomas. Cancer research communications (2023)
Jean-Philippe Guégan, Marjorie Lapouge, Laure Voisin, Marc K Saba-El-Leil, Pierre-Luc Tanguay, Kim Lévesque, Jérémy Brégeon, Anne-Marie Mes-Masson, Daniel Lamarre, Benjamin Haibe-Kains, Vincent Quoc-Huy Trinh, Geneviève Soucy, Marc Bilodeau, Sylvain Meloche
Signaling by the tyrosine kinase Yes promotes liver cancer development. Science signaling 15 (717) (2022)